Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Bone Disorders01:29

Bone Disorders

5.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.5K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.

Archives of toxicology·2021
Same author

Natural polyphenols in preclinical models of epilepsy.

Phytotherapy research : PTR·2020
Same journal

Broussonin A Attenuates Type 2 Diabetic Osteoporosis by Reactivating JAK2/STAT3 Signaling to Inhibit Ferroptosis in BMSCs.

Phytotherapy research : PTR·2026
Same journal

Curcumin as a Multifaceted Epigenetic Modulator With a Disease-Oriented Perspective.

Phytotherapy research : PTR·2026
Same journal

A Critical Review of Cytochrome P450 Enzyme Inhibition by Herbal Phytochemicals: Implications for Drug Interaction Prediction and Herbal Safety.

Phytotherapy research : PTR·2026
Same journal

Curcumol Inhibits the Laminin-Facilitated Malignant Progression in Small-Cell Lung Cancer via Disrupting Laminin-Integrin β1 Interaction.

Phytotherapy research : PTR·2026
Same journal

Bioactive Natural Products in Cardiovascular Disease: Focus on Thrombotic Events.

Phytotherapy research : PTR·2026
Same journal

Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1.

Phytotherapy research : PTR·2026
See all related articles

Related Experiment Video

Updated: Feb 8, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

13.4K

Curcumin in epilepsy disorders.

Ashish Dhir1

  • 1Department of Neurology, School of Medicine, University of California, Davis, CA, 95817.

Phytotherapy Research : PTR
|June 20, 2018
PubMed
Summary
This summary is machine-generated.

Curcumin shows anti-seizure potential in preclinical epilepsy models, but poor brain availability limits clinical use. Further research and clinical trials are needed to resolve bioavailability issues for potential epilepsy treatment.

Keywords:
anti-epileptic drug interactionsbioavailabilitycomorbiditiescurcuminepilepsypreclinical animal models

More Related Videos

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.3K
A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
09:41

A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery

Published on: May 20, 2016

12.7K

Related Experiment Videos

Last Updated: Feb 8, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

13.4K
Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.3K
A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery
09:41

A Pipeline for 3D Multimodality Image Integration and Computer-assisted Planning in Epilepsy Surgery

Published on: May 20, 2016

12.7K

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Curcumin, a turmeric compound, exhibits antioxidant, anti-inflammatory, and neuroprotective properties.
  • Preclinical studies suggest curcumin has therapeutic potential for epilepsy disorders.

Purpose of the Study:

  • To analyze preclinical evidence on curcumin's anti-seizure effects.
  • To highlight the need for clinical trials to validate curcumin's efficacy in epilepsy.

Main Methods:

  • Review of preclinical studies involving chemical and electrical models of epilepsy.
  • Analysis of curcumin's anti-seizure and anti-epileptogenic activities.
  • Evaluation of nanoliposome and liposome technologies for enhancing brain bioavailability.

Main Results:

  • Curcumin demonstrates anti-seizure potential in various acute and chronic epilepsy models.
  • Curcumin exhibits anti-epileptogenic activity, reducing seizure severity in a kainate-induced temporal lobe epilepsy model.
  • Poor brain bioavailability of curcumin is a significant limitation for clinical application.

Conclusions:

  • Curcumin's antioxidant and anti-inflammatory properties may underlie its anti-seizure effects, though mechanisms require further elucidation.
  • Enhanced delivery systems like nanoliposomes show promise for improving curcumin's brain penetration.
  • While preclinical data is promising, randomized clinical trials are essential to confirm curcumin's benefit in epilepsy management.